Clinical Trials Directory

Trials / Unknown

UnknownNCT02894073

Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient

Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient: a Randomized, Controlled Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Placement of a peripheral venous catheter (PVC) is the most common invasive procedure in anaesthesia and perhaps even in the field of medicine as a whole.

Detailed description

Placement of a peripheral venous catheter (PVC) is the most common invasive procedure in anaesthesia and perhaps even in the field of medicine as a whole. This procedure may be challenging in the obese patient - even for the most experienced healthcare professionals. In a study, PVC placement was considered to be difficult in 46% of obese patients but only 13% of non-obese patients. Placement of a central venous catheter is an option when PVC placement is impossible, although central access is associated with a non-negligible risk of complications (pneumothorax, infection, arterial puncture, etc.). Facilitating peripheral venous access in obese patients should shorten the time required for PVC placement, decrease the number of perfusion attempts (a source of dissatisfaction and discomfort for the patients) and limit the use of a central venous catheter. Although a number of novel vein visualisation devices (such as the VeinViewer®Vision from Christie Medical) have been developed to guide PVC placement, there are no literature data on the value of these devices in the management of difficult venous access in obese patients.

Conditions

Interventions

TypeNameDescription
DEVICEskin transilluminatorVeinViewer

Timeline

Start date
2017-03-21
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2016-09-09
Last updated
2018-08-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02894073. Inclusion in this directory is not an endorsement.